Publications

Susceptibility Testing Accuracy of an Enterobacteriaceae Population Enriched for Ctx-M-Type ESBL-Producing Isolates (China): Intermethod Analysis for Nine Important Parenteral ß-Lactams, Lead author: Pottumarthy S, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Importance of Medium, Calcium Concentration, Time of Incubation, and Inoculum for Testing Polymyxin B (PB) against Acinetobacter spp. (ASP) and Pseudomonas aeruginosa (PSA), Lead author: Mendes RE, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Validation of Etest Colistin (CO) and Polymyxin B (PO) against the CLSI Reference Methods using 413 Strains with a Wide Susceptibility Range, Lead author: Bolmstrom A, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Wild-Type MIC Distributions for Campylobacter spp. Tested against Nine Antimicrobials using Recently Approved CLSI Broth Microdilution (BMD) Methods (2005), Lead author: Fritsche TR, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Faropenem Activity Tested against Neisseria gonorrhoeae Including Contemporary Antimicrobial Resistance Phenotypes, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Tigecycline (GAR-936) Activity against 850 Bloodstream Infection (BSI) Isolates of Viridans Group Streptococci, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Antimicrobial Spectrum and Potency of Cefepime Combined with Sulbactam when Tested with 4 Candidate Ratio or Fixed Concentration Formulations, Lead author: Sader HS, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of a Novel Cationic Steroid Antimicrobial (CSA-13) Targeting Aerobic and Facultative Gram-negative Bacilli, Gram-positive Anaerobes and Select Agent Surrogate Strains, Lead author: Savage, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of a Novel Cationic Steroid Antimicrobial (CSA-13) Against Staphylococcus aureus and Bacterial Species Associated with Infections in Cystic Fibrosis Patients, Lead author: Savage, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Antimicrobial Activity of BP-102, A Novel Carbacephem, Tested Against H. influenzae, M. catarrhalis and Various Gram-Positive Cocci, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of VIC-105555 (VIC), a Novel Lincosamide, Tested Against Gram-Positive Bacteria and Anaerobes, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Comparative Antimicrobial Activity and Spectrum of Retapamulin (RE) Against Drug-Resistant Organisms, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Quality Control Guidelines for Testing Retapamulin by CLSI Broth Microdilution and Disk Diffusion Methods, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Assessment of Pathogen Frequency and Resistance (R) Patterns Among Pediatric Patients (PP): Report from the SENTRY Antimicrobial Surveillance Program (2004) on Three Continents, Lead author: Fedler K, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Evaluation of Clinical Outcome among Patients with ESBL-Producing Enterobacteriaceae (ETB) Treated with Cephalosporin (CEPH) Monotherapy, Lead author: Craig WA, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Geographic Antimicrobial Resistance Variability among Bacterial Pathogens Causing Nosocomial Pneumonia in North America (NA): An Eight-Year Analysis from the SENTRY Antimicrobial Surveillance Program, 1997-2004, Lead author: Biedenbach DJ, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of Gemifloxacin Tested against Historical and Contemporary Isolates of Neisseria gonorrhoeae (NG) Including Fluoroquinolone-Resistant Strains (QRNG), Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Contemporary Occurrence of Mobile AmpC-Type ß-Lactamase Resistances (R) in E. coli (EC): Report from the SENTRY Antimicrobial Surveillance Program (USA, 2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Antimicrobial Activity of Broad Spectrum Parenteral Cephalosporins Tested against Bacterial Isolates from Pediatric Patients: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Geographic Occurrence and Resistance Patterns among Pathogens Isolated from Skin and Soft Tissue Infections (SSTI): A Report from the SENTRY Antimicrobial Surveillance Program (2004), Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Antimicrobial Activity of Alternative Broad-Spectrum Agents against Imipenem-Non-Susceptible Gram-Negative Bacilli: Report from the USA MYSTIC Programme, 1999 – 2004, Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Update on Daptomycin Antimicrobial Activity When Tested against Clinical Strains from North American Medical Centers (2004), Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Susceptibility Patterns for Amoxicillin/Clavulanate Tests Simulating Licensed Formulations and Pharmacokinetic Relationships: Does the 2:1 Ratio MIC Accurately Reflect Activity against Beta-Lactamase Producing H. influenzae and M. catarrhalis, Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Re-Evaluation of the Bactericidal Activities and the Correlation between Disk Diffusion and MIC Methods for Testing Daptomycin and Vancomycin against S. aureus with Decreased Susceptibility (S) to Gylcopeptides, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Antimicrobial Activities of Cefepime and Piperacillin/Tazobactam against E. coli and Klebsiella spp. with ESBL-Phenotype Collected Worldwide, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Potential Role for Triple Antibiotic Ointment (TAO) Against Mupirocin-Resistant Staphylococci: A USA and Australian Clinical Isolate Sample, Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Daptomycin Resistance and Vancomycin Intermediate S. aureus in a Patient with Prolonged Antibiotic Therapy, Lead author: Mariani P, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Global Assessment of the Polymyxin B Activity Tested against 55,151 Clinical Strains of Gram-Negative Bacilli: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Spectrum and Potency of Dalbavancin Tested against 3,322 Gram-Positive Cocci Isolated in the USA Surveillance Program (2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Activity of Tigecycline (TIG) Tested Against Non-Fermentative Gram-Negative Bacilli (NFB), Including Imipenem-Non-Susceptible (IMP-NS) Strains, and ESBL-producing Enterobacteriaceae (ENT), Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Persistent Occurrence of Clonally Related Multi-Drug Resistant Acinetobacter Spp. Isolates Within the MYSTIC Programme Medical Centers (USA, 1999 – 2004), Lead author: Rhomberg PR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Potential Options for Parental Therapy of Community-Acquired Infections Caused by Levofloxacin-Resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Fritsche TR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Comparative Antimicrobial Spectrum and Potency of Meropenem Tested Against Enterobacteriaceae and Non-Fermentative Gram-Negative Bacilli: Report from the 2004 MYSTIC Program (USA), Lead author: Jones RN, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Comprehensive In Vitro Evaluation of Cefepime Combined with Aztreonam or Ampicilin/Sulbactam Against Multi-Drug Resistant Pseudomonas aeruginosa and Acinetobacter spp., Lead author: Sader HS, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Antimicrobial Activity of the Novel Peptide Deformylase Inhibitor LBM415 (NVP PDF-713) Against an International Collection of Respiratory Tract, Skin and Soft Tissue Pathogens (2004), Lead author: Watters A, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Influence of Errors Caused by Automated Systems in the Antimicrobial Susceptibility Rates of Pseudomonas aeruginosa against Selected Beta-Lactam Antimicrobials, Lead author: Sader HS, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

In Vitro Evaluation of Dalbavancin in Combination with Other Classes of Antimicrobial Agents, Lead author: Johnson DM, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Reproducibility of Daptomycin MIC Results Using Dry-Form Commercial Trays with Supplemental Calcium Content, Lead author: Rhomberg PR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Evaluation of Bactericidal Activity of Daptomycin and Vancomycin Tested Against Staphylococcus aureus (VISA, hVISA, and wild-types), Lead author: Sader HS, presented at 8th annual International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections, May 22 – 24, 2005, Charleston, South Carolina

Significant Increases in the Rate of Fluoroquinolone Resistance Among Gram-negative Bacilli: Six-year (1999-2004) Report from the USA MYSTIC Programme, Lead author: Rhomberg PR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Accuracy of Three Automated Systems for Susceptibility Testing Selected Gram-negative Bacilli Against Five Broad-spectrum Beta-Lactam Agents, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Susceptiblity Patterns for Amoxicillin/clavulanate Tests Mimicking Newly Indicated Formulations and Pharmacokinetic Relationships: Does 2:1 Ratio MIC Accurately Reflect Activity Against Beta-Lactamase-Producing H. influenzae and M. catarrhalis, Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Diverse Transposons Are Responsible for the Dissemination of Japanese Metallo-beta-lactamase Alleles: Report from the SENTRY Surveillance Programme, Lead author: Toleman MA, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Genetic Characterisation of the IMP-1 Metallo-beta-lactamase Gene in Enterobacter cloacae Strains from Turkey, Lead author: Toleman MA, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Activity of Beta-Lactam Antimicrobial Agent Combinations with Aztreonam When Testing Metallo-Beta-Lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp., Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Transfer and Carriage of Naturally Occurring Pseudomonas aeruginosa Plasmids Harbouring Metallo-beta-lactamase to Enterobacteriaceae Strains, Lead author: Castanheira M, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Activity of Tigecycline Tested Against Bacterial Pathogens from Intensive Care Units, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Potency and Spectrum of Tigecycline Tested Against an International Collection (1999-2003) of Bacterial Pathogens Producing Skin and Soft Tissue Infections, Lead author: Fritsche TR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Tigecycline Activity Tested Against 22,950 Bloodstream Infection Isolates Worldwide, Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Activity of New Compounds Tested Against Multi-Drug Resistant S. aureus Isolated in Latin American Medical Centers (LAMCs), Lead author: Gales AC, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark